Description
Mediven‑S ointment 15 g is a mild topical corticosteroid containing Hydrocortisone. It is specifically indicated for the short‑term management of inflammatory skin conditions such as eczema, dermatitis and non‑infected rashes. By suppressing the release of inflammatory mediators, it rapidly reduces redness, swelling and itching, helping to restore skin comfort and appearance. The occlusive ointment base provides an emollient effect, making it especially suitable for dry, scaly or thickened lesions. This over‑the‑counter (OTC) preparation is intended for external use only and should not be applied to the face, broken skin or open wounds unless directed by a healthcare professional.
Key Features
-
Contains Hydrocortisone, a mild corticosteroid with anti‑inflammatory, anti‑pruritic and vasoconstrictive actions.
-
Effectively treats eczema, dermatitis, rashes and other minor inflammatory skin conditions.
-
Ointment base provides an occlusive, moisturising effect, ideal for dry or scaly skin.
-
Rapidly reduces redness, swelling and itching by suppressing the release of inflammatory mediators.
-
Convenient 15 g tube for targeted application; apply a thin layer once or twice daily.
-
Over‑the‑counter (OTC) medicine, available without a prescription.
Technical Data Table
| Attribute | Specification |
|---|---|
| Product Name | Mediven‑S Ointment 15 g |
| Active Ingredient | Hydrocortisone (typically 1% w/w) |
| Formulation | Topical ointment |
| Therapeutic Class | Mild topical corticosteroid |
| Indications | Eczema, dermatitis, rashes and other minor inflammatory skin conditions |
| Mechanism of Action | Suppresses the release of inflammatory mediators, reducing redness, swelling and itching |
| Route of Administration | Topical (external use only) |
| Dosage | Apply a small amount to the affected area once or twice daily; rub gently until absorbed |
| Prescription Status | Over‑the‑counter (OTC) |
| Storage | Store in a cool, dry place below 25 °C, away from light and moisture |




Reviews
There are no reviews yet.